162 related articles for article (PubMed ID: 36077072)
21. Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2.
Hara I; Hotta H; Sato N; Eto H; Arakawa S; Kamidono S
Jpn J Cancer Res; 1996 Jul; 87(7):724-9. PubMed ID: 8698622
[TBL] [Abstract][Full Text] [Related]
22. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
[TBL] [Abstract][Full Text] [Related]
23. Loss of inducible nitric oxide synthase expression in the mouse renal cell carcinoma cell line RENCA is mediated by microRNA miR-146a.
Perske C; Lahat N; Sheffy Levin S; Bitterman H; Hemmerlein B; Rahat MA
Am J Pathol; 2010 Oct; 177(4):2046-54. PubMed ID: 20709800
[TBL] [Abstract][Full Text] [Related]
24. RENCA/carbonic anhydrase-IX: a murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma.
Shvarts O; Janzen N; Lam JS; Leppert JT; Caliliw R; Figlin RA; Belldegrun AS; Zeng G
Urology; 2006 Nov; 68(5):1132-8. PubMed ID: 17095063
[TBL] [Abstract][Full Text] [Related]
25. Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.
Xu Q; Junttila S; Scherer A; Giri KR; Kivelä O; Skovorodkin I; Röning J; Quaggin SE; Marti HP; Shan J; Samoylenko A; Vainio SJ
Dis Model Mech; 2017 Dec; 10(12):1503-1515. PubMed ID: 29084770
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.
Takeuchi T; Konno-Takahashi N; Kasuya Y; Ogushi T; Nishimatsu H; Kitamura T
BJU Int; 2004 Jul; 94(1):171-6. PubMed ID: 15217455
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
[TBL] [Abstract][Full Text] [Related]
28. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.
Sayers TJ; Brooks AD; Seki N; Smyth MJ; Yagita H; Blazar BR; Malyguine AM
J Leukoc Biol; 2000 Jul; 68(1):81-6. PubMed ID: 10914493
[TBL] [Abstract][Full Text] [Related]
29. Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.
Muraishi Y; Mitani N; Fuse H; Saiki I
Anticancer Res; 2001; 21(6A):3845-52. PubMed ID: 11911256
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
[TBL] [Abstract][Full Text] [Related]
33. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.
Morita T; Shinohara N; Tokue A
Br J Urol; 1994 Oct; 74(4):416-21. PubMed ID: 7529632
[TBL] [Abstract][Full Text] [Related]
34. Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo.
Wu W; Ye H; Wan L; Han X; Wang G; Hu J; Tang M; Duan X; Fan Y; He S; Huang L; Pei H; Wang X; Li X; Xie C; Zhang R; Yuan Z; Mao Y; Wei Y; Chen L
Carcinogenesis; 2013 Jul; 34(7):1636-43. PubMed ID: 23471882
[TBL] [Abstract][Full Text] [Related]
35. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.
Wysocki PJ; Kazimierczak U; Suchorska W; Kotlarski M; Malicki J; Mackiewicz A
Cancer Gene Ther; 2010 Jul; 17(7):465-75. PubMed ID: 20168352
[TBL] [Abstract][Full Text] [Related]
36. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Xu L; Tong R; Cochran DM; Jain RK
Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
[TBL] [Abstract][Full Text] [Related]
38. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
Chou LC; Yang JS; Huang LJ; Wu HC; Lu CC; Chiang JH; Chen KT; Kuo SC; Chung JG
J Gastroenterol; 2009; 44(10):1055-63. PubMed ID: 19688288
[TBL] [Abstract][Full Text] [Related]
39. Characterization of mechanism involved in acquired resistance to sorafenib in a mouse renal cell cancer RenCa model.
Harada K; Miyake H; Kusuda Y; Fujisawa M
Clin Transl Oncol; 2014 Sep; 16(9):801-6. PubMed ID: 24356934
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species-induced apoptosis and reduces cell stemness.
Liou YF; Chen PN; Chu SC; Kao SH; Chang YZ; Hsieh YS; Chang HR
Environ Toxicol; 2019 Nov; 34(11):1208-1220. PubMed ID: 31298468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
